Company Filing History:
Years Active: 2013
Title: Innovations by Stephen C Becker
Introduction
Stephen C Becker is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of antimicrobial research, particularly in combating multi-drug resistant superbugs. With a total of two patents to his name, Becker's work focuses on innovative solutions to persistent health care challenges.
Latest Patents
Becker's latest patents include groundbreaking inventions aimed at addressing the issue of multi-drug resistant bacteria. One of his notable patents is titled "Lys K endolysin is synergistic with lysostaphin against MRSA." This invention highlights the potential of LysK, a staphylococcal bacteriophage endolysin, in combination with lysostaphin to effectively combat MRSA. The study outlines optimal reaction conditions for the recombinant His-tagged LysK protein and demonstrates its antimicrobial activity against various strains, showcasing the synergy between the two agents.
Another significant patent is "Triple acting antimicrobials that are refractory to resistance development." This invention presents a novel antimicrobial endolysin-Lysostaphin triple fusion protein. The protein comprises three functional domains derived from two proteins that exhibit antimicrobial synergy. It is designed to target the peptidoglycan cell wall of bacteria, making it effective against various growth phases and resistant to the development of resistance.
Career Highlights
Stephen C Becker works for the United States of America, as represented by the Secretary of Agriculture. His career is marked by a commitment to advancing antimicrobial research and developing innovative solutions to combat antibiotic resistance. Becker's work has the potential to significantly impact public health by providing new tools to fight against resistant bacterial strains.
Collaborations
Becker collaborates with David M Donovan, contributing to the advancement of research in the field of antimicrobial agents. Their combined expertise enhances the potential for developing effective treatments against multi-drug resistant infections.
Conclusion
Stephen C Becker's innovative work in antimicrobial research exemplifies the importance of addressing the challenges posed by multi-drug resistant superbugs. His patents reflect a dedication to finding effective solutions that can improve health care outcomes. Through his contributions, Becker is making a significant impact in the fight against antibiotic resistance.